Corbus Pharmaceuticals Holdings (CRBP) Times Interest Earned (2013 - 2024)

Corbus Pharmaceuticals Holdings (CRBP) recorded quarterly Times Interest Earned of $4.99 in Q3 2024, up 103.54% quarter-over-quarter from $2.45 in Q2 2024, and up 151.59% on a YoY basis from $1.99 in Q4 2023.

Corbus Pharmaceuticals Holdings (CRBP) Times Interest Earned (2013 - 2024) Analysis & Trends

Corbus Pharmaceuticals Holdings' Times Interest Earned history runs 6 years deep, the most recent figure standing at $4.99 for Q3 2024.

  • In Q3 2024, Times Interest Earned rose 151.59% year-over-year to $4.99; the TTM figure through Jun 2025 stood at -$92.5 (down 1754.55% YoY), while the FY2024 annual figure was $3.37, up 128.85% from the prior year.
  • Times Interest Earned was $4.99 for Q3 2024 at Corbus Pharmaceuticals Holdings, up from $2.45 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $4.99 in Q3 2024 to a low of -$10.86 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 3.58
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -258.33
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - 11.50
7 Psyence Biomedical 238.34 Bn 238.33 Bn - 547.67
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn -
9 Abivax 95.45 Bn 95.45 Bn - 11.79
10 Corbus Pharmaceuticals Holdings 136.49 Mn 108.68 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2024 4.99
Jun 30, 2024 2.45
Mar 31, 2024 1.23
Dec 31, 2023 -10.86
Sep 30, 2023 -9.68
Jun 30, 2023 -8.19
Mar 31, 2016 -449.02
Dec 31, 2015 -2,341.55
Jun 30, 2015 -6,520.85
Mar 31, 2015 -1,568.23
Dec 31, 2014 -1,289.99
Sep 30, 2014 -1,258.77
Jun 30, 2014 -41.34
Mar 31, 2014 -9.46
Dec 31, 2013 -19.99
Sep 30, 2013 -4.84